RMTG stock

Regenerative Medical Technology Group Inc. (RMTG) financials · rev $4.0M

Regenerative Medical Technology Group Inc. (RMTG) rev $4.0M.

Cached annual income statement
LineFY2025FY2024
Revenue$5.1M$4.1M
Cost of Revenue$2.3M$1.3M
Gross Profit$2.8M$2.8M
Operating Income-$867.2K$81.2K
Net Income-$7.8M-$5.6M
EPS (Diluted)$-0.62$-0.44
Cached annual balance sheet
LineFY2025FY2024
Total Assets$4.5M$3.8M
Current Assets$1.2M$1.2M
Cash & Equivalents$956.7K$1.2M
Inventory$159.3K$10.1K
PP&E$870.8K$451.7K
Total Liabilities$39.2M$31.2M
Current Liabilities$36.8M$29.0M
Short-term Debt$0$0
Long-term Debt$0$0
Total Debt$0$0
Shareholders' Equity-$34.7M-$27.4M
Retained Earnings-$75.4M-$67.6M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$706.5K$850.7K
CapEx$602.6K$215.4K
Investing Cash Flow-$602.6K-$215.4K
Financing Cash Flow$1.1M$0
Dividends Paid$0$0
Net Change in Cash$0$0
Free Cash Flow-$1.3M$635.3K

FAQ

What is RMTG P/E and revenue?

Regenerative Medical Technology Group Inc. (RMTG) rev $4.0M.

What is RMTG revenue?

Regenerative Medical Technology Group Inc. last cached revenue is $5.1M (FY2025).

Is RMTG profitable?

Regenerative Medical Technology Group Inc. last cached net income is -$7.8M.

What are RMTG total assets?

Regenerative Medical Technology Group Inc. last cached total assets are $4.5M.

What is RMTG free cash flow?

Regenerative Medical Technology Group Inc. last cached free cash flow is -$1.3M.

Not investment advice. Cached statements, not a live tape.